explore -WSS

explore

author：leisure time 2025-10-01 02:14:39 - browse：56535

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

leisure time

knowledge

WSS

Ahead of JPM, here's who's profiting most in health care

Antibiotic resistance and the global rise in human conflict

UCB departs biotech trade group BIO

Feng Zhang CRISPR delivery startup lays off quarter of staff

New research casts further doubt on a common procedure used with IVF

Retired US general questions alleged Putin, Prigozhin meeting

explore

explore

leisure time

Apple is now the first public company to be valued at $3 trillion

Videos point to link between seizures and unexplained toddler deaths

After affirmative action ruling, medical educators look to 'holistic review'

Ahead of JPM, here's who's profiting most in health care

Hepatitis C has a cure — but many Americans still lack access to it

How the political right came to back psychedelics to treat trauma

Cancer drug shortages should be causing more outrage

Federal weight loss drug coverage is 30 years out of date

Walensky prepares to leave CDC — and Congress — behind

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

knowledge

Oak trusses raised to roof of fire

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Why 40% Americans with Parkinson’s don’t see a neurologist

Living with Fabry disease, a condition that causes chronic pain

Burning questions for the 2024 JPM Healthcare Conference

GSK Flovent asthma inhalers replaced by authorized generics

hotspot

leisure time

knowledge

hotspot